Fadi Bou-Abdallah,* [c] and Robert P. Doyle* [a, b] Vitamin Ab ased bisretinoid accumulationi samajor focus in the study of maculard egeneration.W hether specific endogenous lysosomal proteins can bind A2E, ap ronouncedb isretinoid in lipofuscin granules in retinal pigment epithelial cells, and interfere with enzymatic or photoinduced oxidation of such, hasn ot been explored. Herein,u sing fluorescence and electronic absorption spectroscopy and mass spectrometry,w e demonstrate that Saposin B, ac riticalp rotein in the degradation of sulfatides and "flushing" of lipids, can bind A2E, preventingi ts H 2 O 2 -dependent enzymatic oxidation by horseradish peroxidase andp hotooxidation by blue light (l = 450-460 nm).
The bisretinoid 2-[(1E,3E,5E,7E)-2,5-dimethyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)octa-1,3,5,7-tetraen-1-yl]-1-(2-hydroxyethyl)-4-[(1E,3E,5E)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexa-1,3,5-trien-1-yl]pyridinium (A2E;F igure 1) is am ajor fluorescent component of lipofuscin granules that accumulate in the lysosomes of cells of the retinalp igmente pithelium (RPE) and is implicated in disease processes in age-related maculard egeneration( AMD), recessive Stargardtd isease (SD), and Best vitelliform macular dystrophy. [1] A2E forms non-enzymaticallyinp hotoreceptors adjacent to RPE cells and is transferred (along with other components) through phagocytosis of outer-segment membrane by the RPE.A ll healthye yes accumulate bisretenoids in RPE,w hile all other outer-membranec omponents phagocytosed are degraded. Thus, bisretenoid accumulationi s not the result of active inhibition of lysosomal activity,d ifferentiating any associated disease process from lysosomal storage diseases (LSD). A2E has been extensively investigated [2] and is the focus of therapeutic approaches that strive to reversei ts accumulation in RPE. [3, 4] In 2011, ap roof-of-concepts tudy by Sparrow et al. demonstrated the feasibility of using an "enzyme-replacement" approach to A2E degradation by introducingh orseradish peroxidase (HRP) into ah uman RPE cell line (ARPE-19), reducing A2E levels by 75 %. [5] Although am ajor focus on A2E has been its role in oxidative stress, [6, 7] few studies have demonstrated that A2E can directly interact with endogenous proteins.W ork by Moiseyev et al. has demonstrated that A2E can inhibitn on-palmitoylated, soluble, cytoplasmic retinoid isomerohydrolase (RPE65 isomerohydrolase) by direct binding (K D = 250 nm). [8] Yanagi et al. have demonstratedA 2E to be an endogenousl igand for retinoic acid receptor (RAR), inducing sustained activation of RAR targetg enes. [9] The phenotypic outcomes of such sustained activation includesn eovascularization about the RPE. [9] Interestingly,S parrow et al. have shownt hat conditions that promote A2E aggregation (i.e. nonpolar environments/microdomains) within the lysosome have also been shown to promote photooxidation. [10] Sparrowe tal. have postulated that interactions between A2E and components of the lysosomal milieu, which they describe as possibly including polar and hydrophobic side-chains of proteins (withoutk nown examples), may serve to hold af raction of A2E, available for redistribution amongstl ysosomal microdomains after photobleaching.
We have been interested in the multisubstrate specificity of human lysosomal Saposin B( SapB) and its implications in drug toxicitya nd/or disease progression. [11, 12] SapB is an intralysosomal, non-enzymatic proteinaceous co-factor that binds and presents3 -O-sulfogalactosylceramide( sulfatide) to the active site of arylsulfatase A( ASA) for desulfation to galactosylceramide. [13] Thel ack of functional SapB (or ASA) resultsi nab uildup of sulfatide and the fatal LSD metachromatic leukodystrophy (MLD). [13] Interestingly,p rogressive RPE degenerationh as been reported in patients with MLD. [14] In addition, Barres et al. have shown that sulfatide (but not galactosylceramide) can inhibit optic nerve growth, including the regrowth of damaged optic nerve. [15] SapB has also been shown to "flush"b ound ligand,s uch as coenzyme Q10 (CoQ 10 ), in human urine. [16] Given this understanding, and taking into accountt he intralysosomaln ature of A2E accumulation, we hypothesized that SapB would bind A2E. Herein, we present evidence, using electronic absorption and fluorescences pectroscopiesa long with mass spectrometry,t hat SapB binds A2E (K D = 25 mm)w ith an observed binding stoichiometry of 2:1S apB:A2E, and that such binding protects A2E from both enzymatic and photooxidation.
As pectrophotometric titration of SapB with A2E was first carried out. A2E [17] andS apB [18] werep repared and purified according to literature reports. To determine the A2E/protein binding stoichiometry,afluorescence titration (monitoring the emission of tyrosine in SapB at l = 308 nm) was carried out by incrementally adding small amounts of A2E to as olution of SapB ( Figure 2 ). The quenching of the fluorescence intensity at 308 nm exhibited ad iscontinuitya ta bout 0.5:1 A2E/protein, suggesting the formation of ap rotein-A2E complex with one A2E ligand bound per SapB dimer.Adouble logarithmic plot of log A2E has maximum absorbance bands around l = 340 nm and 440 nm and an emission spectrum centered around l = 600 nm (with an excitation wavelength l exc = 440 nm;s ee Figure S1A in the Supporting Information). When exciteda t 278 nm, SapB has an intensef luorescencee mission at 308 nm whereas A2E has very weak or residual fluorescence, in comparison. When excited at 308 nm, A2E has av ery weak emission spectrum as shown in Figure S1B . Thus, the spectrophotometric titrationo fS apB with A2E reported in Figure 2i sf ollowing the quenching of the emission of SapB upon A2E binding, with little to no interference ('inner-filter" effect) from A2E fluorescence. Furthermore, the fact that the fluorescence emission of A2E at 605 nm shows ab reak at 0.5:1 A2E/SapB (Figure 3 ) is in support of the fluorescenced ata at 308 nm suggesting that the quenching is due to A2E binding and to A2E quenching the emission intensity of SapB. We note that SapB has no fluorescence at 605 nm when the excitation wavelength was set to 440 nm. Moreover,w hen A2E is titrated into SapB and the absorbance followed between 300 and 410 nm, al inear relationship is obtained suggesting, once again,t hat the observed break at 308 nm in Figure 2i sd ue to binding of A2E to SapB with little to no effect due to A2E (see Figure S2) .
We have reported in an earlier study the binding properties of SapB to CoQ 10 (a bona fide substrate). [18] To determine whether A2E binds to the same binding site on the protein as CoQ 10 ,aseries of fluorescence titration experiments (following the emission spectra of A2E at 605 nm) in the presence and absence of CoQ 10 were performed. Figure 3s hows an ear-identical fluorescencet itration pattern when A2E is titrated into aS apB protein solutiona lone or as olution of SapB pre-complexed with CoQ 10 (SapB:CoQ 10 ) complex .T hese datas uggestt he hitherto unknown presence of as econd binding site on SapB, in this case for A2E. The similarity of the titration curves in Figure3also suggests that the A2E binding site on SapB is not alteredb yt he presence of CoQ 10 andt he affinity of SapB to A2E has not significantly changed, in support of an on-cooperative and distinct binding site forC oQ 10 and A2Eo nS apB. This is further corroboratedw ith the experimentally calculated dissociationc onstant for A2E binding to the SapB:CoQ 10 complex (K D % 52 mm,d etermined using rectangular hyperbola/nonlinear regression), [19, 20] av alue similar to that for A2E bindingt o SapB alone(reported herein at % 25 mm).
Since HRP is reportedt oo xidize the bisretinoid A2E, [5] we thought to examine whether SapB can protect A2E from oxidative transformationsb yH RP.W hen H 2 O 2 is added to as olution of A2E containing HRP,adecrease in the absorbance value of A2E at 340 nm is observed (Figure 4 ) supporting that A2E acts as ar educing substrate fort he HRP/H 2 O 2 system,a se xpected. [5] When the experiment was repeated in the presence of A2E pre-complexed with SapB (2:1 SapB:A2E ratio;b lue line), the absorbance change was very similar to, but less than, that of ac ontrol mixture of HRP and H 2 O 2 ( Figure 4 ; green line), supporting ap rotective role of SapB for A2E. Given we observe ac urve for the (SapB-A2E) complex (blue line, Figure 4 ) that displays less change in relative absorption at 340 nm than the HRP/H 2 O 2 control, we thought to check if the minor decrease in relative absorbance for the (SapB-A2E) complex was not due to partial A2E degradation,b ut rather SapB interaction with HRP mitigating degradation of the HRP enzyme by H 2 O 2 .F igure S4 shows the oxidative decay of A2E fluorescencea t6 05 nm by HRP/H 2 O 2 in the absence and presence of SapB. Over the course of 400 min, A2E exhibited no fluorescenced ecay in the presenceo fS apB supportingaprotective role of SapB for HRP, perhaps via protein-protein association.T oc onfirm this latter hypothesis, af luorescence quenching experiment following incrementala dditions of HRP to SapB was performed ( Figure S5) . The results demonstratearelatively strong interaction between SapB and HRP with ab inding constant of 1 10 6 m
À1
and as toichiometry of 1:1.
Havinge stablished the presence of two different binding sites on SapB (one for A2E and one for CoQ 10 ), we also tested the ability of SapB to protect A2E in the presence of CoQ 10 ( Figure 4, FigureS3) . The addition sequence (SapB-A2E) complex + CoQ 10 + HRP + H 2 O 2 ( Figure S3 ) or the sequence (SapBCoQ 10 ) complex + A2E + HRP + H 2 O 2 ( Figure S3 ) showed absorbance values similar to the sequence (SapB + A2E) complex + HRP + H 2 O 2 ,aresult consistent with the fluorescenced ata of Figure S5 and in strong support of ap rotectiver ole of SapB for A2E. By contrast, ac ontrol experiment consisting of the addition sequence A2E + CoQ 10 + HRP + H 2 O 2 exhibited as imilar absorbance curve to that in the absence of CoQ 10 ( Figure S3) , supporting A2E oxidation.
We screened A2E photostability to blue light (450-460 nm 12W blue LED), whether in its free form or complexed to SapB (2:1 SapB:A2E;s ee the Supporting Information for details) in 50 mm phosphate buffer with 1% methanol or 1% DMSO or 0.1 mm SDS (the latter two being known facilitators of bluelight-induced A2E photooxidation). [10] The decline in absorbance is indicative of A2E oxidation ( Figure 5 ), ar esult confirmed by electrospray mass spectrometry ( Figures S6-S8 ), which shows significant oxidative reduction of A2E when bound to SapB over aperiod of 30 min.
Based on the invariable slopes for all experiments with A2E bound to SapB (Figure 5 ), it appears there is ac onstant protection factor at work, one not significantly affected by the external solvent polarity/environment, and counter to such environmental effects observed for oxidation of "free" A2E with blue light. [10] The fact that SapB might play ar ole in mitigating photooxidation and then providing as ource of subsequent fluorescence upon re-equilibriumb etween (SapB-A2E) complex and A2E levels is an interesting possibility,a nd in line with the Sparrow hypothesis. [10] The feasibility of A2E redistributionw ithin the cell associatedw ith SapB is made more relevant again in light of recent studies by Yamamoto et al. showing that SapB could regulate CoQ 10 movement/levels within HepG2 cells. [21] A2E has been reported to not interferew ith ASA specific activity,b ut the experiments were conducted without time-dependenti nhibition assays, accounting for equilibrium rates of the binding partners involved or knowledge of A2E interaction with the activator (i.e. SapB). [22] Subsequents tudies have demonstrated that ad elay in activity of ASA is likely that results in gradual, long-term accumulation of lipids. [23] Louis and Fluharty demonstrated that activator-dependent hydrolysis of myelin cerebroside sulfate by ASA could be affected in terms of slower hydrolysis rates by competition for activator by "other lipoidalc onstituents", as yet still unknown. [24] Based on the data herein, it is likely that SapB binding of A2E would result in competition between A2E and ASA for activator,e ven temporarily, which would be as ignificant problem for ac ircadian process. [25] In summary,w ed emonstrate that A2E binding by the lysosomal protein SapB prevents A2E oxidationb yH RP or blue light. Such binding may then complicate attempts to produce an enzyme replacementt herapy for A2E degradation/photooxidation and/orp lay ar ole in the "transport" or movement of A2E inside the cell (and possibly out of the cell). It would be of interestt oa ssay the urineo fpatients with AMD or SD for the presenceo f(SapB-A2E) complex ,especially since (SapB-CoQ 10 ) complex has been observed, therein. [16] Finally,t he possibility of A2E competition for activators uggests an eed to assay for sulfatide build-up in patients with AMD or SD.
